Vimarsana
Biggest News Aggregation in the World

Page 3 - Cigna Group Express Scripts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cigna Group Express Scripts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cigna Group Express Scripts Today - Breaking & Trending Today

Cigna to Add 3 Humira Biosimilars to Drug Reimbursement List - Vimarsana News

Cigna to Add 3 Humira Biosimilars to Drug Reimbursement List

Cigna Group's Express Scripts pharmacy benefits unit will add three biosimilar versions of AbbVie's blockbuster arthritis treatment Humira to its list of preferred drugs, the company said on Monday.

Health News Roundup: Schumer asks FDA to investigate Logan Paul's PRIME energy drink; Court reinstates Tennessee ban on care for transgender youth and more - Vimarsana News

Health News Roundup: Schumer asks FDA to investigate Logan Paul's PRIME energy drink; Court reinstates Tennessee ban on care for transgender youth and more

The panel of three judges voted 2-1 to reverse a lower court's decision that had blocked Tennessee from enforcing the law while it was being challenged. EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.

Fresenius Launches Biosimilar Version of AbbVie's Humira - Vimarsana News

Fresenius Launches Biosimilar Version of AbbVie's Humira

The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid arthritis drug, will be at a 5% discount to Humira's list price.

Fresenius launches biosimilar version of AbbVie's Humira at 5% discount | WSAU News/Talk 550 AM · 99.9 FM - Vimarsana News

Fresenius launches biosimilar version of AbbVie's Humira at 5% discount | WSAU News/Talk 550 AM · 99.9 FM

(Reuters) - The generic drug unit of Germany's Fresenius said on Monday the price for Idacio, its copycat version of Abbvie's top-selling rheumatoid a...

Source: wsau.com
Fresenius launches biosimilar version of AbbVie's Humira at 5% discount - Vimarsana News

Fresenius launches biosimilar version of AbbVie's Humira at 5% discount

Fresenius joins drugmakers Boehringer Ingelheim, Sandoz and Organon, which launched Humira biosimilars, or copies of biologic drugs, this week. Industry experts have said that most new biosimilars are expected to debut with marginal discounts to Humira's monthly price of $6,922.

Source: aol.com